Details for Patent: 8,076,362
✉ Email this page to a colleague
Summary for Patent: 8,076,362
| Title: | Crystal modification A of 1-(2,6-difluorobenzyI)-1 H-1,2,3-triazole-4-carboxamide and dosage forms and formulations thereof |
| Abstract: | The invention relates to dosage forms and formulations comprising the novel crystal modification A of the compound I-(2,6-difluorobenzyl)-I H-I,2,3-triazole-4-carboxamide, wherein crystal modification A is characterized by characteristic lines with interplanar spacings (d values) of 10.5 .ANG., 5.14 .ANG., 4.84 .ANG., 4.55 .ANG., 4.34 .ANG., 4.07 .ANG., 3.51 .ANG., 3.48 .ANG., 3.25 .ANG., 3.19 .ANG., 3.15 .ANG., 3.07 .ANG., and 2.81 .ANG., determined by means of an X-ray powder pattern. Dosage forms of crystal modification A of the compound I-(2,6-difluorobenzyl)-I H-I,2,3-triazole-4-carboxamide may be for oral or parenteral administration, in the form of a solid or liquid, and in a dosage range of 20 mg to less than 500 mg. Solid dosage forms comprise a tablet or capsule, and further comprise a pharmaceutically-acceptable carrier and film-coat. |
| Inventor(s): | Portmann; Robert (Pratteln, CH), Hofmeier; Urs Christoph (St. Pantaleon, CH), Burkhard; Andreas (Basel, CH), Scherrer; Walter (Rheinfelden, CH), Szelagiewicz; Martin (Munchenstein, CH) |
| Assignee: | Novartis AG (Basel, CH) |
| Application Number: | 12/767,003 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; |
Drugs Protected by US Patent 8,076,362
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,076,362
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Switzerland | 1404/97 | Jun 10, 1997 |
International Family Members for US Patent 8,076,362
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0994863 | ⤷ Sign Up | CA 2007 00037 | Denmark | ⤷ Sign Up |
| European Patent Office | 0994863 | ⤷ Sign Up | 91345 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 0994863 | ⤷ Sign Up | 300284 | Netherlands | ⤷ Sign Up |
| European Patent Office | 0994863 | ⤷ Sign Up | SPC026/2007 | Ireland | ⤷ Sign Up |
| European Patent Office | 0994863 | ⤷ Sign Up | 07C0037 | France | ⤷ Sign Up |
| European Patent Office | 0994863 | ⤷ Sign Up | 303 | Finland | ⤷ Sign Up |
| European Patent Office | 0994863 | ⤷ Sign Up | C00994863/01 | Switzerland | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
